These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 19951408)
1. A multicenter, double-blind, randomized, controlled phase III clinical trial of chicken type II collagen in rheumatoid arthritis. Wei W; Zhang LL; Xu JH; Xiao F; Bao CD; Ni LQ; Li XF; Wu YQ; Sun LY; Zhang RH; Sun BL; Xu SQ; Liu S; Zhang W; Shen J; Liu HX; Wang RC Arthritis Res Ther; 2009; 11(6):R180. PubMed ID: 19951408 [TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind, multicenter, controlled clinical trial of chicken type II collagen in patients with rheumatoid arthritis. Zhang LL; Wei W; Xiao F; Xu JH; Bao CD; Ni LQ; Li XF Arthritis Rheum; 2008 Jul; 59(7):905-10. PubMed ID: 18576295 [TBL] [Abstract][Full Text] [Related]
3. [Adalimumab plus methotrexate for the treatment of rheumatoid arthritis: a multi-center randomized, double-blind, placebo-controlled clinical study.]. Huang F; Zhang FC; Bao CD; Tao Y; Gu JR; Xu JH; Zhu P; Xu HJ; Zhang ZY; Zhao DB; Wu DH Zhonghua Nei Ke Za Zhi; 2009 Nov; 48(11):916-21. PubMed ID: 20079321 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of low-dose glucocorticoids combined with methotrexate and hydroxychloroquine in the treatment of early rheumatoid arthritis: A single-center, randomized, double-blind clinical trial. Hua L; Du H; Ying M; Wu H; Fan J; Shi X Medicine (Baltimore); 2020 Jul; 99(27):e20824. PubMed ID: 32629668 [TBL] [Abstract][Full Text] [Related]
5. A comparative study of etanercept plus methotrexate and methotrexate alone in Taiwanese patients with active rheumatoid arthritis: a 12-week, double-blind, randomized, placebo-controlled study. Lan JL; Chou SJ; Chen DY; Chen YH; Hsieh TY; Young M J Formos Med Assoc; 2004 Aug; 103(8):618-23. PubMed ID: 15340661 [TBL] [Abstract][Full Text] [Related]
6. A clinical study of CPH 82 vs methotrexate in early rheumatoid arthritis. Lerndal T; Svensson B Rheumatology (Oxford); 2000 Mar; 39(3):316-20. PubMed ID: 10788542 [TBL] [Abstract][Full Text] [Related]
7. Golimumab, a human anti-tumor necrosis factor alpha monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis. Emery P; Fleischmann RM; Moreland LW; Hsia EC; Strusberg I; Durez P; Nash P; Amante EJ; Churchill M; Park W; Pons-Estel BA; Doyle MK; Visvanathan S; Xu W; Rahman MU Arthritis Rheum; 2009 Aug; 60(8):2272-83. PubMed ID: 19644849 [TBL] [Abstract][Full Text] [Related]
8. Polymerized-type I collagen for the treatment of patients with rheumatoid arthritis. Effect of intramuscular administration in a double blind placebo-controlled clinical trial. Furuzawa-Carballeda J; Fenutria-Ausmequet R; Gil-Espinosa V; Lozano-Soto F; Teliz-Meneses MA; Romero-Trejo C; Alcocer-Varela J Clin Exp Rheumatol; 2006; 24(5):514-20. PubMed ID: 17181919 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety results from a Phase 3, randomized, placebo-controlled trial of subcutaneous golimumab in Chinese patients with active rheumatoid arthritis despite methotrexate therapy. Li Z; Zhang F; Kay J; Fei K; Han C; Zhuang Y; Wu Z; Hsia EC Int J Rheum Dis; 2016 Nov; 19(11):1143-1156. PubMed ID: 26259617 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness of Yishen Tongbi decoction versus methotrexate in patients with active rheumatoid arthritis: A double-blind, randomized, controlled, non-inferiority trial. Xu J; Zhang L; Xu Y; Yu J; Zhao L; Deng H; Li M; Zhang M; Lei X; Hu C; Jiao W; Dai Z; Liu L; Chen G Phytomedicine; 2023 Apr; 112():154704. PubMed ID: 36796186 [TBL] [Abstract][Full Text] [Related]
11. Subcutaneous administration of polymerized-type I collagen for the treatment of patients with rheumatoid arthritis. An open-label pilot trial. Furuzawa-Carballeda J; Cabral AR; Zapata-Zuñiga M; Alcocer-Varela J J Rheumatol; 2003 Feb; 30(2):256-9. PubMed ID: 12563677 [TBL] [Abstract][Full Text] [Related]
12. The AMPK modulator metformin as adjunct to methotrexate in patients with rheumatoid arthritis: A proof-of-concept, randomized, double-blind, placebo-controlled trial. Abdallah MS; Alarfaj SJ; Saif DS; El-Naggar ME; Elsokary MA; Elsawah HK; Abdelsattar Zaki S; Wahsh EA; Abo Mansour HE; Mosalam EM Int Immunopharmacol; 2021 Jun; 95():107575. PubMed ID: 33773207 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate. Schiff M; Keiserman M; Codding C; Songcharoen S; Berman A; Nayiager S; Saldate C; Li T; Aranda R; Becker JC; Lin C; Cornet PL; Dougados M Ann Rheum Dis; 2008 Aug; 67(8):1096-103. PubMed ID: 18055472 [TBL] [Abstract][Full Text] [Related]
14. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial. Lambert CM; Sandhu S; Lochhead A; Hurst NP; McRorie E; Dhillon V Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477 [TBL] [Abstract][Full Text] [Related]
15. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study. Smolen JS; Han C; Bala M; Maini RN; Kalden JR; van der Heijde D; Breedveld FC; Furst DE; Lipsky PE; Arthritis Rheum; 2005 Apr; 52(4):1020-30. PubMed ID: 15818697 [TBL] [Abstract][Full Text] [Related]
16. Abatacept plus methotrexate provides incremental clinical benefits versus methotrexate alone in methotrexate-naive patients with early rheumatoid arthritis who achieve radiographic nonprogression. Wells AF; Westhovens R; Reed DM; Fanti L; Becker JC; Covucci A; Keystone EC J Rheumatol; 2011 Nov; 38(11):2362-8. PubMed ID: 21885491 [TBL] [Abstract][Full Text] [Related]
17. Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial. Cohen S; Hurd E; Cush J; Schiff M; Weinblatt ME; Moreland LW; Kremer J; Bear MB; Rich WJ; McCabe D Arthritis Rheum; 2002 Mar; 46(3):614-24. PubMed ID: 11920396 [TBL] [Abstract][Full Text] [Related]
18. [Clinical study of Biqi Capsule combined with methotrexate for treatment of rheumatoid arthritis]. Jie HY; Wu QF; Ding ZX Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Feb; 32(2):195-8. PubMed ID: 22574592 [TBL] [Abstract][Full Text] [Related]
19. Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: results through 2 years of the GO-FORWARD study extension. Keystone EC; Genovese MC; Hall S; Miranda PC; Bae SC; Palmer W; Wu Z; Xu S; Hsia EC J Rheumatol; 2013 Jul; 40(7):1097-103. PubMed ID: 23678153 [TBL] [Abstract][Full Text] [Related]
20. The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression. Atsumi T; Yamamoto K; Takeuchi T; Yamanaka H; Ishiguro N; Tanaka Y; Eguchi K; Watanabe A; Origasa H; Yasuda S; Yamanishi Y; Kita Y; Matsubara T; Iwamoto M; Shoji T; Okada T; van der Heijde D; Miyasaka N; Koike T Ann Rheum Dis; 2016 Jan; 75(1):75-83. PubMed ID: 26139005 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]